[Form 4] IonQ, Inc. Insider Trading Activity

Rhea-AI Filing Summary

IonQ, Inc. (IONQ) – Form 4 insider transaction dated 07 July 2025

Director Kathryn K. Chou exercised 5,000 stock options at an exercise price of $4.61 (Code M) and immediately sold the same 5,000 common shares on the open market at $46.18 (Code S) under a pre-arranged Rule 10b5-1 trading plan adopted 12 March 2025.

Following the transactions she directly owns 67,628 shares of IonQ common stock. Her remaining unexercised option position totals 44,900 shares from an original 63,900-share grant that vests in three equal annual instalments through 11 July 2025 and expires 11 July 2032.

The sale represents approximately 7.4 % of her direct equity stake, signalling partial profit-taking while retaining a majority holding.

Positive

• Director retains 67,628 shares, demonstrating continued equity exposure and alignment with shareholders.
• Transaction executed under a pre-planned Rule 10b5-1 program, reducing potential insider-information concerns.

Negative

• Insider sold 5,000 shares at $46.18, suggesting profit-taking and marginally increasing short-term supply.
• Remaining 44,900 options could lead to future dilution when exercised.

Insights

Securities Analyst

TL;DR: Small director sale offset by option exercise; ownership remains sizable – neutral overall impact.

The simultaneous option exercise and share sale is typical liquidity management. Chou monetised roughly $207k in gains (5,000 × $41.57 spread) but still holds 67,628 shares, indicating continued alignment with shareholders. The transaction was executed under a 10b5-1 plan, reducing concerns about information asymmetry. The scale (<1 % of IonQ’s float) and lack of multiple insiders make the filing not materially impactful to the investment thesis.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kramer Thomas G.

(Last) (First) (Middle)

C/O IONQ, INC.

4505 CAMPUS DRIVE

(Street)

COLLEGE PARK MD 20740

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IonQ, Inc. [ IONQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2025		S(1)		72,000	D	$42.2555(2)	646,516	D
Common Stock								5	I	By child

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.59 to $44.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Stacey Giamalis, Attorney-in-Fact	07/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many IonQ (IONQ) shares did Director Kathryn Chou sell?

She sold 5,000 common shares on 07 July 2025 at $46.18 each.

Did Kathryn Chou exercise stock options in this Form 4?

Yes. She exercised 5,000 options at an exercise price of $4.61 (Code M).

What is Chou’s current IonQ share ownership after the transaction?

She directly owns 67,628 shares of IonQ common stock.

Is the transaction part of a Rule 10b5-1 trading plan?

Yes, the filing states it was executed under a Rule 10b5-1 plan adopted 12 March 2025.

How many unexercised options does Chou still hold?

She retains 44,900 unexercised options from the original 63,900-share grant.